Agios Pharmaceuticals, Inc (AGIO) Covered Calls

Agios Pharmaceuticals, Inc covered calls Agios Pharmaceuticals Inc is engaged in the development of medicines to treat the cancer metabolism and inborn errors of metabolism, which are a subset of orphan genetic metabolic diseases.

You can sell covered calls on Agios Pharmaceuticals, Inc to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for AGIO (prices last updated Fri 4:16 PM ET):

Agios Pharmaceuticals, Inc (AGIO) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
51.53 -1.72 51.53 51.80 446K - 0.0B
Covered Calls For Agios Pharmaceuticals, Inc (AGIO)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Dec 21 50 2.45 49.35 1.3% 59.3%
Jan 18 50 4.70 47.10 6.2% 62.9%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

Agios Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in cellular metabolism to transform the lives of patients with cancer and rare genetic disorders of metabolism, or RGDs, which are a subset of rare genetic diseases. The company's products include IDH1 AND IDH2, PKR, II D-2 hydroxyglutaric aciduria, AG-221 and AG-120. Agios Pharmaceuticals was founded by Lewis Clayton Cantley, Tak W. Mak and Craig B. Thompson on August 7, 2007 and is headquartered in Cambridge, MA.